1

f��N�ùôûãÿ�

�

�e�

l ¢�¡ ]�

�

.6 ¡¨ / § E

2

jR�

�

 ���eÛO��

�

¡��NMÚ�Öá�viU4�

� ¡� ��'�(Ñ'�t�

� ¡�¡��NMÛ�ÞA�

� ¡�¢���eÛNMH?Ñ;�CF�

� ¡�£��NMH?Û��Øn�

� ¡�¤��NMÛ�&�

� ¡�¥��5LgT*Õ� ZÚÔÕáf���@Û�à7Ó�

�

¢��zX$iNM�

� ¢� ���z`��8��±¾Ã»¿¿ÂËÊÁÄ»ÊÁÅÄ�²ÄÀÁ¼ÁÊÁÅÄ©�±²�9�Y&T�

� � ¢� � ���w��

� � ¢� �¡��zX�a�

� � ¢� �¢��±¬ 9�Û&��

� � ¢� �£��±² G���

� � ¢� �¤���viÙU4�

� � ¢� �¥���Ûj%�

� ¢�¡��²¿³ �p d9�Y&� �²¿³�®²¬��

� � ¢�¡� ���Ûj%�

� ¢�¢��²¿° �p d9�Y&� �²¿°�®²¬��

� � ¢�¢� ���Ûj%�

�

£����#$iNM�

� £� ��¹»Ç³»Ä ÷āĄöâcÓ×þãÿîäú ·¹�¶­· T�

� � £� � ���Ù�wăQ��

� � £� �¡��e�\ ·´¬ âcÓ×��ÛD���

� � £� �¡� ��e�\ ·´¬Û,��

� � £� �¡�¡��2VÛ�{�

� � £� �¡�¢� þãÿîäú ·¹�¶­· �2�

3

� � £� �¡�£� ñĄî|J�

� � £� �¢�NMÛ'B�

� � £� �¢� �åäÿí ·´¬:��

� � £� �¢�¡��e�\·´¬Û�=�

� � £� �¢�¢��eåäÿíéõúÛN��

� � £� �¢�£���6kI��

� � £� �¢�¤� �&�

� � £� �¢�¥� òýöÿÝÛ)2�

� £�¡� êĂøĂìüóÿ ·¹�ľÉʾ½� ¶­· Tċ�P�xh�ą´¸Ć��#"-

T�

� � £�¡� �¹ÍÅ�ÉÊ¾Æ TÚßá�eåäÿí ´¸��#ÛN��

� � � £�¡� � ��w�

� � � £�¡� �¡�åäÿí ·´¬:��

� � � £�¡� �¢������2ą·¹Ć�

� � � £�¡� �£�� ÉÊ�¶­· ÔßÜ Ä¾Éʾ½�¶­· �2�

� � £�¡�¡��µÄ¾�ÉʾÆ�·¹�¶­· TÚßá�eåäÿí ´¸��#ÛN��

� � � £�¡�¡� ��w�

� � � £�¡�¡�¡�µÄ¾�ÉʾÆ�·¹�¶­· ÔßÜ ´¾Éʾ½�¶­· �2�

� £�¢���eåäÿí ®  ��#ÛN�ÔßÜ��#|J�

� � £�¢� ���w�

� � £�¢�¡�� ÉÊ�¶­· ÔßÜ Ä¾Éʾ½�¶­·�

� � £�¢�¢��¶­· b^Ûo{ØïäĀèòìĄèçĂí�2�

� � £�¢�£�� ìĄèçĂísKÛ|J�

� £�£�� þãÿîäú ·¹�¶­· ÔßÜêĂøĂìüóÿ ·¹�¶­· Û�3êĂòā

Ąÿ�

�

¤�� åäÿí���

� ¤� ���cqu�

� ¤�¡����AT�

� ¤�¢���&AT�

� � ¤�¢� ��y�9�T�

�

4

¥��N�åäÿíÛ��T�

�

¦��1c>_�

�

§��NM����

�

¨��<}+S�

�

 ����mt�

�

5

 �� �eÛO� � ɡ` Togavirus ɼ Rubivirus Ž_£±� RNA zy³�Y<pɡz

y³�_ȘƩdz]mUXƒC˵IJqpơƢƩdzɤY<o5ƩdzƘ;

_ȸÚǥtʞXɦɤMp6ɦɄ38~39+ ¹ɦɡ÷˷Ƣ_Źʙǐl

ʙ˄Âɡ ¹²·�ʏʼʹÆ]ʰÒƘ5@mbƘB¼ÆƝY<

p6ɦɄ¹ɦɡ`ǍǗYȧŠMpB5²·�ʏʼʹ`;ƹʢMp6

ƭÑY`ʏȾ_ɤɋkKaKa˪jnqpB5eZu[`»Ƣ]ʝƣM

p6ʀ]ˎŹǯȭźƢʛǐɣlʸȾʊ_įáɤt˛pIZk<pB5ŒǨɪ

]ÊƘ`˃ţ\ɢƤY<p6gR¿ƢƩdzkŹõY 30~50%5ƭÑY 15ʁƎũŋMpZ˟sqX=pZZk]5¼ÆƝ_÷XBǃs\=ŔįkśE5

I_m>\ŔįʾƋ˦ǒ`ńY<o5ǼǴ˦ǒB˚Y<p6gR5 ɡ5

ȴˎƢɑˆ]mpɦɡ5ÛdzƢʙǐ5|·�µzy³�ƩdzɤʊZć

˦ǒBƟ˚Z\pIZB<o5ǼǴ˦ǒBǣĕY<p6 � ɡ]ôɠ_Ɂ=ŢƢBŤŦąǥɊ]¸Ǣ×ú]ɡzy³�]Ʃ

dzMpZ5P_āɓõ]òŞƢɡɤëʬCongenital Rubella Syndrome : CRS tɦɤMpIZB<o5ŝC\ľZ\p6CRS _ŝɤɋ`ɨú5

òŞƢƞɢƤ5ʱY<pB5P_Óʤʽɤ5ˎŹǯȭź5ʲʺʼ5˷ß@

mbʔɺ_ɦƐ\[tÜ>IZk<p6CRS _ǼǴ¹˦ǒ©�®w³`

8òŞƢɡɤëʬ9_]ˣM6 Ɖƭ 26 Ɗ 4 Ǣmo8Ku]MpɊůƩdzɤÊƺ9BɦĕJq5ɡ

_˦ǒ]@GpǼǴ˦ǒ_ƗďBmo˚Z\UR 1)6 ¡�� NMÚ�Öá�viU4�

�

¡� �� '�(Ñ'�t�

� ɡzy³�`�±�_ɣġß]ĂJqX=p_Y5P2 ŰǕˤY

BSL2 _ĩoư=Œȳ]ƙUXàǽtː>6 ˨ʯ`ÊjɡƳßåtȰůK5ƳßBɁ=AÞ=ŔįHI Ƴßå 16 ê

×¾]`ɡ¶��·tǁʂK5Ƴß_ɍƚl½Ǚtɷ˪KXAnǼǴ]

ƙËMpIZBǤgK= 2)6 ¡�¡�� NM�@Û�ÞA�

6

� ɡ_ǼǴ˦ǒZKX5ˎȫūɪǔȚ@mbɣġßǼāȚBĈɕīʵY<

p˓ 6ˎȫūɪǔȚZKX`5IgM ƳßǼāȚ5IgG ƳßȰůȚ@mb

˴ˎɑÿƲĉHIƳßȰůȚ\[BĈɕīʵY<pB5ơƢǥ_ˎȫt

ɕ=p IgM ƳßǼāȚB»˂ɪY<p6 � ɣġßǼāȚZKX`5ĻƸ=Ȩ5ˎȨ5Ż\[tǼß]KXzy³�

Ă@mbzy³�ÛŧǼāBīʵY<p6zy³�Ă`ĂİůgY

]ǜBAApIZ5@mbĂīʵ\ǼßǀĩǜǥBzy³�ÛŧǼā

mokɵǥY<pIZʊAn5gN`zy³�ÛŧǼāȚtː>IZB

»˂ɪY<p6 ¡�¢�� �eÛNMH?Ñ;�CF�

� zy³�Ă@mbzy³�ÛŧǼā_ǼǴǩǑZKX5ɡZù_

ʾƋǩǑĻƸ=Ȩ5ÿŇȉǧǺˎȨ5Ż3,4)BǂšJqp6ɡY`

ʻƸ=Ȩ5ȨkǼǴǩǑZKXâɕīʵY<p6ɡɊɞɪƳß_Ǽā

]`ˎȫgR`ˎȷtɕ=p6ǼǴǔȚ`ɣġßǼāȚZˎȫūɪ˦ǒ

Ț]ĂAqp6PqQq_ǼǴ]`ă\Ǽß5ǼßǀĩǜǥB<p�˓ ��6 ˓

ǼǴǔȚ Ǽß ǀĩ]ă\ǜǥ

cRT-PCR real-time PCR

ɣ

ġ

ß

Ǽ

ā

zy³�Ă

ĻƸ=Ȩ5ˎȨ5

Ż5ʻƸ=Ȩ5

Ȩ

ɦɤ2-3ǗċAnɦɤƘ1ʁƎ

IgM ƳßǼā

(IgM ELISAȚ)

ˎȫ ɦɤƘ4Ǘ;28Ǘɭ ˎ

ȫ

ū

ɪ

ǔ

Ț

IgG ƳßåȰ

ů (IgG ELISAȚʊ)5HIƳßȰů

ˎȫ¦wˎȫ 1Ńɭ:ɦɤċ;ɦɤƘ4ǗɭgY 2Ńɭ: 1Ńɭ_ǀˎAn2;4Ƙ5ɦɤƘ 2;4Ƙ

7

Iqn_Ǽß_ĀɒǔȚ_ãtƻHp6 1) Ļ@mb^F=ȨgR`ʻƸ=Ȩ zy³�Ăő@mbÛŧǼ

Ǵ įƭȅʶʚǩ_�¶¢ǀĩ��x��ãSterile Swab Applicators, Copan ɹ˗ YĻ<p=`ʻʓʽt^F=5zy³�çũ˼Ȩ

;3mL]ȦȶMp6zy³�çũ˼Ȩ`Ƅ˰ļãBD ¯��º�

³�±·�¨º�Ǽß˼ɕőŌ5BD ɹ˗_eA5ʿųˮǎȨBâ

ɕYCp6Ǽß` 3,000rpm, 20 ĂƞK5½ȫtǼǴ]ɕ=p6 0.5%z�ˎȫw³¢ª·¡±��°· VBSA 5¦��²· G

100-500U/mL 5��´£�©y�·100-500µg/mL 5�·�©y

�·100µg/mL@mbw·¡}�²�· B2µg/mLtȪđKR

ʜʴőɕőŌMEM őŌʊgR` PBS(-)tɕ=p6

2) ÿŇȉǧǺˎȨzy³�Ăő@mbÛŧǼǴ �|·��²z«gR` EDTA đǧǺˎȨtɕ=p2;5mL 6¤�

²·đǧǺˎȨ_Ŕį`5RT,PCR ħƠtŲMpRj5zy³�Ă

ő_h]äMp6ɡǼǴZİǜ]ː>Ŕį]`5ǀˎJqRÿŇȉ

ˎȨ`×¾_=NqA_Āɒljàtː=5ǧǺˎĝǷɑʜʴPBMCt

ĂKX˨]äMp6ɡǼǴ_h_Ŕį`5÷ˎ5ˎȫ5ˎȷtɕ=

Xk˃=6 ǔȚ ÿŇȉˎȨ 2mL ]ʊ_ PBS tȩĺMp6 <nALj Ficoll-paque ȑ 1.077 3mL tĂȜKRƞ�®º¢

] 2 êƆKRˎȨtA]žMp6 1,300)g520 ĂƞMp6 ˓žAn]ˎȷʘêƆ 5ǧǺˎĝǷɑʜʴPBMC 5ȑ

Ȩ@mb˴ˎɑƭĂ]ĂəJqp6PBMC `zy³�Ă@mb

ÛŧǼǴ]äMp6\@ˎȷ`zy³�ÛŧǼāĦbzy³�Ă

\nb]»_ƳßåȰů���tɕ=RƳßåȰů]âɕYCp6 ĂəJqR PBMC ` PBS YŃȟȢƘ5þʟçũȨ10%DMSO

8

đz�ʳõˎȫFBS ]Ʈů_ȻƎ2)104;2)106 cells/mlYˮǎK5-80+YþʟçũMp6İǿ]ˎȷ`-20+»`zy³

�ĂɕZKX-80+]çũMp6

ǔȚ ÿŇȉˎȨt 3,000rpm520 ĂƞMp6 ƞJqRȨ_½ž`ˎȷəĂ5¾ž`ˎɑəĂ_ž]ĂəJqp6

ˎɑəĂ˓ž_ɨ˄tĶMpʜʴƭĂt�³µº�x·���£ʊ

]moŃĨMp6 ŃĨJqRʜʴtñ__zy³�˼çũȨgR`ʜʴʣƹɕő

Ȩ]ûȤKXǼßZMp6 P_Ó_əĂ`ǔȚ]ȳLXçũMp6

ǔȚ ˎȷƭĂZ²·�ɑ_ĂȚ

� ˎȨtűȯY ����&%"5�� ĂƞMp6�

� ˎȨƭĂBȩöK\=m>½ȫˎȷƭĂtŃĨMp6�

� ˎȨƭĂ]ǀˎ_ �êZ\pm>] ��� tđ?pǀˎB "!

\na5��"! Z\pm>] ��� tđ?p 6�

� �y·�µº�ºtɕ=XűȯY ����&%"����������5�� Ăƞ

Mp�

� ½ȫ�êƆJqRˎȷƭĂZ²·�ɑĂȨ_Ŗɚ]ƖƭJ

qR²·�ɑžtŃĨMp6�

� ŃĨKR²·�ɑ]ê×½_ ��� tđ?5űȯY �������5��

ĂƞKXȟȢMp6I_ljàtˡŃː>6ˎȷƭĂ5²·�ɑ

tçũMp6�

3) Żzy³�Ăő@mbÛŧǼǴ

10 An 50mL _ŻtǀĩMp61,000;1,500rpm510 ĂƞKRȗȮ

ʜʴt 2;3mL _zy³�˼çũȨ]ûȤJORk_tɕ=p6ȗȮ

ʜʴBƚnq\AURŔį]`ŻǼßtP_ggâɕMp6zy³�Ă

]ǦĀɒŻǼßtâɕMpŔį5P_ggSZʜʴŲB˵CpIZB<

pRj 2~10 ê]ƆKXâɕMp6

9

4) ʸʷȨzy³�Ăő@mbÛŧǼǴ5ƳßåȰů ǀĩJq

RǼßtP_ggɕ=p6 � ˎȫ5ˎȷƳßåȰů ˎȨǀĩƘ5ĂKXâɕMp6�

�

�� ˎȫ5ˎȷzy³�ÛŧǼǴ�ǼßAn ����"%���&�!�����"�#�� �'�

��w�·ɹ��ʊY ����tƵāKâɕMp6�

7) ÷ˎ (zy³�ÛŧǼǴ): Nuclospin RNA Blood (��±�y~ɹ)ʊt

ɕ=X ÷ˎmo RNA tƵāKâɕMp6 ¡�£�� NMH?Û��Øn�

ǼßtǀĩKRn+]çʍK5lA]ǼǴŰǕǕˤcýˈɋƪY˼M

p6ǀĩƘ 48 ǜ×ú]zy³�ÛŧǼāȚ<p=`zy³�ĂȚB

ťYCpŔį]`P_gg 4+YçũMp6ǼǴťBǀĩƘ 48 ǜt˶?

pŔįlǥçũ_Ŕį]`-80+]çũMp6ˎ ȫūɪǼǴ]ɕ=pˎȫ`

���+YçũMp6 ¡�¤�� NMÛ�&�

� Ȉ_=NqA<p=`˘Ǎ_ʟDzBƚnqRŔį5ɡzy³�ƩdzƢ

ZĆůMp6 ɡzy³�BĂ¹İůJqp ɡzy³�ÛŧBǼāJqp6 ɡzy³�Ɋɞɪ IgM BǼāJqp6 ¦wˎȫơƢǥ@mbŃƛǥ]@=Xɡzy³�Ɋɞɪ HI Ƴß

<p=` IgG Ƴß _˸5gR` HI Ƴßå_ê×½_½Ǚ 2) <

p=` IgG Ƴßå_ê×½_½ǙB˪jnqp6

� IgM Ƴß_Ȱů`Ƈ]ǣɕY<pB5ƓƢ_Ŕį`ƟNKkǡ˿_

ɡzy³�ƩdztħǛMp˥Y`\=_YȜƧBƟ˚Y<p6ƢƩdz_Ŕ

į5ɦɡBāɐKXAnEZkǗƘ]` HI Ƴß@mb IgM Ƴß_½Ǚ

B˛nqp6]5ɦɡɮƘ0;3 Ǘ_ˎȫY`Ŕį]mUXƢZYp

10

IZB<p_Y5ˎȫ_ǀĩǜǥ]`ȜƧt˚Mp6 ¡�¥�� 5LgT*Õ� ZÚÔÕáNM�@Û�à7Ó�

� ɡ`ƩdzɤȚ]@GpÍƩdzɤ_>T÷ǍƱdžƩdzɤ]ƺůJqX@

o5÷X_Ěɥȇ`ɡƤʯt˦ǒKRŔį5żātː>IZBůjnq

X=p6ɡ_żāŒȳ]@=X`58÷˷Ƣ_Źʙǐlʙ˄Âɡ958ɦɄ9

@mb8²·�ʏʼʹ9_VMdX_ʾƋɤɋtɸKRɤãtʾƋ˦ǒã

ZMpZůjnqX=p6KAK5¼ƝëBMdXPrs\=ŔįkśE5

P_Ŕį`żāŒȳtȲRMRj]ǼǴ˦ǒBƟ˚Z\p6 ¢�� zX$iNM�

¢� �� �z`��8�ą±¾Ã»¿¿ÂËÊÁÄ»ÊÁÅÄ�²ÄÀÁ¼ÁÊ ÁÅÄ©�±²Ć9�Y&T ¥�§��

����������

¾ˣ]ˮ˗ǔȚtɸM6=NqkƄ˰ļB<qaÕǠYCp6 �~²·Āɒɕ˨ˉ

1. PBS(,)Dulbecco _ PBSpH7.2;7.4 NaCl 8.0g, KCl 0.2g, Na2HPO4 1.15g, KH2PO4 0.2g tˇɛȓ]ȴ

˞K÷t 1,000ml ZMp6 2. 25%�~²·ƬȺȨ

�~²·Fisher gR` Aldrich ˗25g ] PBS(,) 100ml tđ?

Xà˗Mp6�~²·` PBS(,)Y 3 Ńȟ>6½ȫ_ pH B 7 ×½

Y<pIZtɷ˪KRn5Ȩ_JtLjƷċ]VGRĞ]<sO

p6 ˴ˎɑɕ˨ˉ

1. DGVDextrose-Gelatin-Veronal NaCl 8.0g5¥µ�º³ 0.575g5¥µ�º³-Na 0.375g5CaCl2 0.02g5MgSO4¹7H2O5�±�· 0.6g5¢�zʕ 10g tˇɛȓ]ȴ˞K5

÷t 1,000ml ZMp6 2. ��°z˴ˎɑȤȨ

��°z˴ˎɑ`Ƅ˰JqX=p6Pqt DGV YŃȟUR<Z5

DGV YȤȨtà˗K5 +]çũMp6ǀˎƘ 3;4 ç

ũYCp650ȤȨ`âɕɮċ]58ȤȨt 1500rpm 10 Ă

11

ƞK½ȫtƿXRƘ5ʊ_ DGV tđ?à˗Mp6HI ˨

Y`Ƙ_ƆȨY 0.25ȤȨtàoâɕMp6

ĮʂƆȨ 1. PBS pH.8

NaCl 9.0g5Na2HPO4 0.67g5KH2PO4 0.72g5NaN3 1.0g tˇɛȓ

]ȴ˞K÷t 1,000ml ZMp6 � � � 2. �³�z«©���z«Ȩ

CaCl2 4.0g5MgCl2¹6H2O 4.0g tˇɛȓ]ȴ˞K 100ml ZMp 3. 1�±�·

�±�· 1.0g ]ˇɛȓ 100ml tđ? 115+10 ĂŊȵˆMp6Ź

ĂĂȜK54+]Xçũ6âɕǜ]ȯȥYZAM6 3. ƆȨƳġ@mbˎȫƆȨ

PBS pH6.8 200ml ]Ɉˎȫw³¢ª· 0.2g51�±�· 1.0mltđ?Rk_tâɕMp6

4. ƆȨ˴ˎɑȤȨà˗ɕƆȨ ƆȨ 200ml ]_�³�z«©���z«Ȩml tđ?p6

HA˴ˎɑÿʚHemagglutininƳġ HA Ƴġ`þʟÈɅJqRk_BƄ˰JqX=p�·�ɓɶʊ 6

¢� �¡�� zX�a�

� ˎȫÅ]` HA ħƠtƲĉMpɊɞɪy·���ºBũŋMp_Y5Ê

j�~²·Āɒ]mUXIqtĩoE6gR˴ˎɑ]ŷMpʿɂÿʚ`5

ŝ_˴ˎɑYĵĨMp6ïĘJqRˎȫY`5y·���ºBG\=

Ŕįk<p_Y5ïĘKRˎȫ`ɕ=\=6ƳßƢZƢ_Ĥʮˎȫk

İǜ]ĀɒMp6ˎȫĀɒ`×¾]ɸM©y�µ£´º�gR`©y�µ�

®º¢Yː>6 ćĆùäèā÷ĀĄòT�

i) Ɖƌ©y�µ£´º�_ʃt»V@C]â>6˔ǼˎȫĮ 25*l töqp

ņ 6 ii) 25%�~²· 0.1ml NVtˎȫ_öUX=pʃ]=qp6�~²·B¿Ŏ

»]\n\=m>]5ǜ7�~²·ȨtûȤJOʚǘEĂȜMp6

12

iii) £´º�½_ȓĂtƸCĩUXAn�º³Mp6 iv) £´º�tƯYȹKEƼp6űȯ] 20 ĂNjʪMp6 v) £´º�tƼURƘ5£´º�ƞȇY 1500rpm53 ĂƞMp6 vi) ƞƘ`£´º�tȓƉ]çƹK�º³ʃîtȼnJ\=m>]K5�

º³t`BM6 vii) Įʃ] 8%˴ˎɑȤȨt 50*l @mb PBS(-)t 25*l đ?p viii) ûb�º³tK5£´º�t˹EƼUX˴ˎɑtmEȩĺJOp6 ix) £´º�t 4+] 1 ǜAn 1 Ŝ@E6I_ 2 Ǝ£´º�tƼUX˴ˎ

ɑtûȤJOp6 x) £´º�tƞ1500rpm53 ĂKXAn�º³t`BM6I_½ȫ

BĀɒȬh 1:8 ƆˎȫZ\p6

ņ� ©y�µ£´º�Y_ˎȫ_�~²·Āɒ Ɖƌ©y�µ£´º�_ʃt 1 V@C]â>6

�

ĈĆùäèāðûĄöT�

i) ˎȫ 50*l t 1.5ml _©y�µ�®º¢]Zp ii) PBS-t 150*l đ?p iii) 25%�~²·Ȩt 200*l đ?5ȹKEƼp6űȯ 20 ĂNjʪ5P_] 253 ŃɬMp iv) 2000rpm20 ĂƞƘ5½ȫtć_©y�µ�®º¢]ɿM6 v) 50%˴ˎɑȤȨt 12.5*l đ?5Ȕȥ] 1 ǜ@Eĥ` 4+1 ŜNjʪMp6

13

I_5ǜ7�®º¢tƼUXˎɑtûȤJOp6 vi) 2000rpm520 Ă 4+YƞƘ5½ȫtŃĨMp6Iqt 1:8 ƆˎȫZM

p6 ¢� �¢��±¬ 9�Û&��

HI˨tŰǕMpċ]5âɕMpHAƳġ_ĐåtȰůK\EX`\n\=6 1) ƆȨ 1 tɕ=X HA ġȨt 1:2 ]ƆK5P_ 50*l t 96 ʃ U ƌ©y

�µ£´º�_ʃ No.1Ȅ]@=RŔį_ǡkƂʇ_Ą]Zp6İ

Lk_tĄVEo5HA Ɔt 2 Ąİǜ]ː>m>]Mp6gRƟ˚ m

o˩ʜ] HA ůtŰǕKR=Ŕį]]ƠLXġȨt 1:3 @mb 1:10]ƆKRk_kĄİǜ]ƆMp6

2) ƆȨ 1 t No.2 An 12 gY 25*l NVđ?p 3) 2 êȍƆt No.11 _ĄgYː>No.12 _Ą`ˎɑŷɃZKXâɕ 4) ƆȨ 1 tĮʃ] 25*l NVđ?p 5) Įʃ] 0.25%˴ˎɑȤȨt 50*l đ?p 6) £´º�tMF]©y�µ£´º�ª��º\[tɕ=5mEȩĺJOp

ɽNVŃ 6ˎɑ_ȩĺBěĂY\=Z¿ŭ÷ÿBʢC HA _ů

BȊɷ]ː?\E\pŔįB<p6 7) £´º�týˈƏ4-10+]ǜʪE 8) £´º�tűȯ]SKX 5-10 ĂƘ]£´º�t˝ŶKʟDztĆůMp6

ŭ÷gR`ĂÿKRʝǧ_ƆêǍt5P_HAġȨ_HAåZMp6

I_ìt T ZMpZ5HA ġȨt T/4 ê]ƆȨ 1 YƆKRȨ4 ĝÝ

HA _Đå]ɯƕt HI ˨]âɕMpƳġZMp6ã?aġȨ_ HAåB 32 _Ŕį]`ġȨt 8 êƆKRk_t HI ˨]âɕMp6

¢� �£��±² G���

U ƌ©y�µ£´º�_ʃtņ_m>]ƼoĂGp6

14

�

ņ� Ǽß@mbŷɃ_©y�µ£´º�½Y_´ywz�ã�

�

1) ĀɒȬhˎȫt<HI ˨>_ 1:8 _ʃ] 50*l5<ˎȫŷɃ>_ 1:8 _ʃ]

25*l Zp6Ó_ʃ]`ƆȨt 25*l NVöqp6 2) 2 êȍƆtː> 3) <HI ˨>_ʃ]ˮ˗KR HA Ƴġ 25*l NVt5<ˎȫŷɃ>_ʃ]Ɔ

Ȩt 25*l NVđ?p6©y�µª��ºʊYȩĺƘ5űȯ] 1 ǜNj

ʪMp6 4) HA Ƴġ_ 2 Ȉůtː>6<HA ÌȈů>_ 1:1 Ɔ_ʃ]<HI ˨>

_ʃ]đ?R_ZİLƳġt 50*l öqp6Ƙ`ò]dR HA ˨_˚

YêȍƆŰǕƘ5ƆȨt 25*l đ?p6 5) 0.25%˴ˎɑȤȨ 50*l NVtMdX_ʃ]đ?ěĂ]ȩĺMp6 6) £´º�týˈƏ4-10+]ǜʪE6 7) <HA ÌȈů>Y HA åBĝÝY<pIZtɷAjp6ƳßƢ@mb

ƢŷɃtˤůKX=pŔį`5ŷɃˎȫ_ HI åBȊKEYX=pAt

ɷ˪Mp6×½BȲRJqRŔį5˨ƭʅZMp6ˎȫŷɃ]@=

XʿɂÿʚBũŋMpǼß`5ˎȫĀɒtûƎŰǕK5ûǼǴMp6 8) HA ħƠtŭ÷ȉKRǡʝƆêǍt5P_ˎȫ_ HI ƳßåZKXĆ

ůMp6

15

¢� �¤�� �viÙU4�

HI ƳßȰů]Ɵ˚\˨ˉB���]\UX=pǼǴ˨ˉk˰ŘJqX@o

âɕBīʵY<p �·�ɓɶ ɡzy³� HI ˨ 8ɓɶ95R-HI8ɓɶ96

I_m>\ǼǴ���tâɕMpŔį]`���_âɕˬǚǟ]ƙ=ljàĆ

ůtː>Ɵ˚B<p6 �

¢� �¥�� �Ûj%�

HI ˨Y`5ɡɊɞɪ IgM, IgG @mb IgA _=NqkħƠK5ʦįɪ\ ƳßåZKXȰůJqpIZAn5ʟDz_˞]`ěĂ\ɒ˞BƟ˚Y<p6 IgG BȰůJqpIZAn5Ʃdz_˦ǒɭɪ_âɕ]`¦wˎȫtɕ=pƟ

˚B<p6ơƢǥ@mbŃƛǥ_ 2 ɀ_ˎȫtȰůK5˸<p=`ê×

½_Ƴßå_½ǙB˪jnqqa5ɡzy³�_ƩdzB<URZĆǒYC

p6»ǔY5HI ˨Y` IgM kǼāMpIZAn5= HI Ƴßå`ɮ

˿_ɡƩdztħǛK>pīʵƢB<o5P_Ćů]`ʾƋɤɋʊtĴjě

Ă\ǼˢBƟ˚Y<p6ƢƩdz_Ŕį5»˂]ɦɡBāɐKXAn 4 ǗƘ

]` HI Ƴß_½ǙB˛nq5ɦɡāɐƘ 1-2 Yǡå 1:256 An 1:8192ʁƎ]Mp67 ¸ǢAn 3 ƊƘEn=gY`5128 êʁƎ_ƳßåYŬ

ůMp6512 ê×½_ƳßåBɦɡāɐƘ 7 ¸Ǣ×½ƹʢMpIZ`\=Z

ʮ?nqX=p6ƙUX 512 ê×½_Ƴßå_Ŕį`5ąƩdzƘ 7 ¸Ǣ×ú

A5ûƩdz]mp¢º��ºY<pīʵƢB=6 ¢�¡��²¿³ �p d9�Y&� �²¿³�®²¬��

ǁȚ\nb] IgM ƳßƾƽȚ]mp EIA ���Z_ʂB<oƄ˰J

qX=p6=Nq_���kâɕˬǚǟ_ˣ˻]ƙUXljàKĆůMp6 ¢�¡� �� �Ûj%�

���_ĆůŒȳ]ŒWCĆůtː>6ąƩdz_Ŕį5ɡzy³�Ɋɞɪ

IgM `ɦɡāɐƘǍǗYǼāJqťj5ɦɤƘʁƎY º�]K5

ɦɤ¸ǢƘgY]ǼāJq\E\pZJqp6ɦɡāɐǗgY`5ěĂ

] IgM BɔɓJqN5ʘĜǍYǼāJq\=IZ]ȜƧBƟ˚Y<p6ƹʢ

ǥ]V=X`éÑƃBŝCE5ǥ]sRUXƹʢƢtɸM�º�k<

pƓƢ_IZBś= 6gR5Ó_Ʃdzɤ]mUXɊɞɪ]ƓƢZ\

pIZk<p6

16

ûƩdz_ŔįYkɤã_ʘ 50] IgM ƳßBǼāJqp_Y5IgM Ƴß_

ǣɁSGY`ąƩdzZ_Ćć`ńY<p6»˂]ûƩdzãY`5ƹʢǥ

BɵEƳßåkÞ=6 ¢�¢��²¿° �p d9�Y&� �²¿°�®²¬��

ǁȚ_ EIA ���BƄ˰JqX=p6=Nq_���kâɕˬǚǟ_ˣ˻

]ƙ=ljàKĆůMp6 ¢�¢� �� �Ûj%�

ơƢǥ@mbŃƛǥ_¦wˎȫ_Ƴßåtİǜ]ȰůK5Ƴß_˸<p=

`5ê×½_½ǙB<URŔį5ɡzy³�ƩdzB<URZĆůYC

p6

17

£�� ��#$iNM�

ǨʆY`ǼßkKE`Ăzy³�An_ɡzy³�ÛŧǼā@mb

Ûŧŏ˞ǰȚtˣ˻Mp6 ɡzy³�Ûŧ_ǼǴ]`5TaqMan £µº¢tɕ=R²w³�y«

RT-PCR Ț5gR`�·¥·�°�³ RT-nested PCR Ț Ǿˋɨ˳ NSÛŧŗƈȚBĈɕYCp6²w³�y« RT-PCR Ț`ʒæƢ5˾Ƣ]

MFq5ÀVŰű�·�ª�º�°·_²��BÞȭYCpIZAn5ʉ

»ƴZKXǂšJqp6»ǔY5²w³�y« RT-PCR Ț`�·¥·�°

�³ RT-nested PCR ȚNS ÛŧŗƈȚZȑ˺KXllƩƎBĒpIZ

An5moĢŵ\ĆůBȕjnqpŔįòŞƢɡɤëʬ_¡}µºw�

£ǼǴ5ŤŦŢƢ_ɡʫƤ_˦ǒʊ]`5�·¥·�°�³ RT-nested PCR ȚtƴMpIZBǤgK=6 Jn]ɡzy³�ƢY<URǼß]V=X`5�·¥·�°�³

RT-nested PCR ȚE1 ÛŧŗƈȚYŗƈKRɔɉtɕ=X5Ûŧ

Ą˞ǰ@mbÛŧŏȖůtː>IZBǂšJqp 1)ņ 6

ņ� ɡzy³� RT-PCR ŗƈÝ

18

£� ��¹»Ç³»Ä ÷āĄöâcÓ×þãÿîäú ·¹�¶­· T�

˸üħƠ@mb PCR ħƠt�·�³�®º¢Yː> TaqMan £µº¢t

ɕ=R one-step ²w³�y« RT-PCR Țtˣ˻Mp6IIY`5ãZKXw

£±y��y~���«�ɹ_TaqMan Fast Virus 1-Step Master Mix@m

b Applied Biosystems 7500 Fast ²w³�y« PCR ���«tɕ=RǔȚ

tɸM6Ó_˨ˉ@mbȇłtɕ=pŔį]@=Xk5×¾_Ư]ȳLX

ŰǕMp6Ǩ Real-time RT-PCR Ț`5ɡzy³� Real-time RT-PCR Ț

4)ZİLħƠǫÙȯƎ@mbħƠǜY<pIZAn5İ»_£´º�Y

ÄːKXŰǕMpIZBīʵY<p6 £� � �� �Ù�wăQ��

zy³�RNAƵā���ã: QIAamp Viral RNA mini kit ; �w�·ɹ

Real-time RT-PCRɕ©��ºª���ã: TaqMan Fast Virus 1-step Master Mix ; w£±y��y~���«�ɹ

©y�µ ¦��ĮŴ_k_

¡x³�ºÔC ¦����£½ˣ_©y�µ ¦��]ŷƠKRk_

1.5ml |�¦·�³¡�®º¢ǷÞĵɳ�y£ã ������$��#���(���

��"�|�¦·�³¡ɹtǂš

1.5ml |�¦·�³¡�®º¢ɕýğƞȇ 96well reaction plate (ã: Fast 96-well Reaction Plate (0.1mL); w£±y�

�y~���«�ɹ) £´º��º³ (ã: Optical Adhesive Covers; w£±y��y~���«

�ɹ) Ûŧŗƈ˕ʪ ã: Applied Biosystems 7500 Fast ²w³�y« PCR ��

�«; w£±y��y~���«�ɹ RNase free ȓ £±y©º@mbǼāɕ£µº¢ £±y©ºȜ

NS(32-54)Fwd: 5’- CCTAHYCCCATGGAGAAACTCCT -3’ (10µM) NS(143-160)Rev: 5’- AACATCGCGCACTTCCCA -3’ (10µM)

19

Ȝã±y©º_<nALjª���Į 10µMKRk_tˮǎK

Xk˃=6P_Ŕį-20+çũK5þʟˍ˞tǍŃ×ú]Ʋ?XâɕMp6 ȩįŕŒ H ` A, C, TG ׌, Y ` C, Tpyrimidine ŕŒZMp6

£µº¢Ȝ NS (93-106) Probe: 5’ FAM-CCGTCGGCAGTTGG-MGB 3’ (10µM) Ȝ10 µM ]ˮ˗KRk_t RNase-free _ȵˆ�®º¢ʊ]ĂȜK5

þʟˍ˞tǍŃ×ú]Ʋ?XâɕMp6

Ƣ�·�µº³ ¹ɡĤɃ RNA Ȝ

ȜňʅƩdzɤɶʄƮzy³�ʉ¼ʉÌűmoƅMp6 £� �¡� �e�\·´¬âcÓ×��ÛD���

� Ûŧŗƈ˕ʪ_ȇʂlµ��]mUXǼāƩƎBsNA]ɞ\pIZB

<p_Y5ąjXŰǕMp]`×¾_ª£� �¡� «�ª£� �¡�£«tĮǕˤ]

@=XƟNː=5˨ʖtǡĘMp6gR5ůǥɪ]gR`Ɵ˚]ƠL

XŰǕMpIZ]mo5ȇł_ƩƎ�{��]\p6 £� �¡� � �e�\ ·´¬ Û,� . ɡĤɃ RNA _ġȨ1×106 � º/5µltȔ½Yȴ˞KRƘ5LjƷK

spin down Mp6 / �®º¢ 1 Ǩ] 95 µl _ȓ<p=` RNA Ɔɕ��¡vºã��±

�y~ EASY Dilution for Real Time PCRtĂȜK585×1049Z±¥³M

p6 0 �®º¢ 4 Ǩ] 90 µl _ȓ<p=` RNA Ɔɕ��¡vºã��±

�y~ EASY Dilution for Real Time PCRtĂȜK585×103985×1029

85×101985×1009ZPqQq±¥³Mp6 1 ɡĤɃ RNA _ġȨ1×106� º/5µl 5µl t585×1049�®º¢]đ

?5LjƷK spin down Mp5×104� º/5µl Z\p 6 2 85×1049�®º¢_ 10 µl t85×1039�®º¢]đ?5LjƷK spin downMp6 3 2Zİǿ]585×1039An85×1029585×1029An85×1019ZɿKX=

20

C585×1009gY_ 10 êȍƆtà˗Mp6 4 85×1049 20 µlNV]ĂȜƘ5-70+×¾YçũK58ɡĤɃRNA 5×104

� º/5µl 9ZKX5ȈŃ×_ǡĘ]ɕ=p6P_`5½ˣ_2×

_Ɔtː>6 £� �¡�¡� �2VÛ�{�

×¾5Applied Biosystems 7500 Fast ²w³�y« PCR ���«tâɕ

_Ŕį . £±y©ºª���5£µº¢54×TaqMan Fast Virus 1-Step Master Mix tȔ½Yȴ˞K5ȩĺKX@E6 / Ȕ½]�®º¢tʪC5×¾]ƙUX57 z{³Ăz{³ĂĎ

_ħƠȨtˮ˗Mp6

�

  �2Ò

×à�ÏÂ��

¦ �2�~

�ÏÂ�� r[0�

·´»É¾�¯È¾¾�ͻʾÈ� ¤�¨� £ �¢� �

£Ð¹»Ç³»Ä�¯»ÉÊ�ºÁÈËÉ� �ÉʾÆ�³»ÉʾÈ�

³ÁÎ� ¤� ¢¤�  Ð�

´¸�¢¡�¤£�¯Í½�� �ϳ��  �§�  ¡�¥� ¨��ij�÷ýäùĄ�

´¸� £¢� ¥��·¾Ì�� �ϳ��  �§�  ¡�¥� ¨��ij�

� �

�

�

�

� ´¸��¨¢� �¥��¶Èż¾�� �ϳ�� ��¤� ¢�¤� ¡¤�ij�

� �§ åæÿ�Ú�U�  ¤� � �

ëĂ÷ÿ ·´¬� ¤� � ��

� � �~� ¡�� � �

0 96well reaction plate _ 6 z{³]5/_©��ºª���t 15 µl NV

ĂȜMp6 1 RNase-free ȓ@mb8£� �¡�  �e�\ ·´¬ Û,�9Yà˗KRɡ

ĤɃ RNA 85×104985×103985×102985×101985×1009_ 5 ʂt 5 µlNVŷƠMpz{³]đ?p6 5×104;5×100� º/ħƠZ\p 2 £´º��º³YŸtKRƘ5ħƠȨt˹E� ·�z·Mp6

21

£� �¡�¢� þãÿîäú ·¹�¶­· �2�

Applied Biosystems 7500 Fast ²w³�y« PCR ���«]���K5×

¾_ǫÙYħƠtː>6 / %�/

Assay/ Absolute Quantification (Standard Curve)/Run Mode/ Standard 7500/Reporter/ FAM/Quencher None Ȝ

�� �� KGJT�

1. ('��� 509 5� 1

2. ('�+ �� 959 20� 1

959 15� 3. PCR��

609 1� 50

Ȝ 5ɡzy³���«Ǽāɕ£µº¢`ˌó�|·�­ºtȂ˯KX

=pRj5�|·�­ºZKX TAMRA tȂ˯KRɡzy³� N ÛŧǼ

āɕ£µº¢ 4)Z`ˤůBɞ\p6Reporter @mb Quencher `z{³ȏ]

ˤůYCp6 £� �¡�£� ñĄî|J�

ɌʅKR3Ń_˨tŰǕK5×¾_V_ŒȳtȲRKX=pIZtɷ˪M

p6 . ȍƆKRɡĤɃRNAYà˗KRǼʧ_slopeB-3.1An-3.8_

Y<pIZ6 1�y�³Y2ê_DNAǒɆ]ŗƈMpɒƦɪ\PCR ħƠ_Ŕ

į5slope`-3.32]\p6 / ȍƆKRɡĤɃ RNA Yà˗KRǼʧ_ R2ìB 0.98 ×½Y<p

IZ6 0 5×101� º/ħƠ_ɡĤɃ RNA B Ct≦40 YǼāJqpIZ6 1 Ƣ�·�µº³Y<pȓBƢCt>40Y<pIZ6 RSK5Ǽʧ` Ct=40 ×úYǼāYCRƆgYYà˗Mp Ƈ55×101

;5×100� º/ħƠ 6 Iqn_ǫÙtŬůKXȲRJ\=Ŕį`5ȇł_ǵȊ5˨ˉ_ûˮǎ\

22

[tǼˢMp6 £� �¢� NMÛ'B�

£� �¢� � åäÿí·´¬:�� �

zy³�RNAvRNA_Ƶā`���ȪÔǏǟ]ȳLXː>6 İǜ]ȓtǼßZKXRNAƵātː=5RNAƵā_Ƣ�·�µº³ZKX

âɕMp6 ƵāRNA`5-70+×¾YçũMp6 £� �¢�¡� �e�\·´¬Û�=�

5×101 @mb 5×100 � º/ħƠ_ĤɃRNAƆȨÌɀtƢ�·�µº³

ZKXâɕMp6ĮǕˤ_ɋș]ƠLXȻƎtřǞYCpB5ȻƎĤɃ

RNA`5×101� º/ħƠt˶?\=m>]Mp6�·�ªtGpRj5

ȻƎ_ɡĤɃRNAtƆMpàǽ`5˨Zć_ŔƮYː=5ĂȜKX

-70+×¾YçũMp6 £� �¢�¢� �eåäÿíéõúÛN��

¾˓]ŒW=XƟ˚\˨ˉtˡʌMp6Ǽß׌]Ɵ˚\�·£³`5.

Ƣ�·�µº³ȓ 5/RNA Ƶā_Ƣ�·�µº³ȓtǼßZKX

RNA ƵāKRk_ 50Ƣ�·�µº³ÌɀġĊZKX 5×101 @mb 5×100 � º/ħƠ_ɡĤɃ RNA_ 4 VY<p6ħƠȨ_ˮǎ@mbħ

ƠǫÙ`ĉ£� �¡�¢� þãÿîäú ·¹�¶­· �2ĊZİǿ]ː>B5Ćů]

` Ct=40 gYKAâɕK\=_Y5PCR ħƠ�y�³Ǎ` 40;50 _ʐŅY

řǞBīʵZMp6 �   �2Ò×à�ÏÂ��

·´»É¾�¯È¾¾�ͻʾÈ� ¤�¨�

£Ð¹»Ç³»Ä�¯»ÉÊ�ºÁÈËÉ� �ÉʾÆ�³»ÉʾÈ�³ÁÎ� ¤�

´¸�¢¡�¤£�¯Í½�� �ϳ��  �§�÷ýäùĄ�

´¸� £¢� ¥��·¾Ì�� �ϳ��  �§�

´¸��¨¢� �¥��¶Èż¾�� �ϳ�� ��¤�

ëĂ÷ÿ ·´¬� ¤�

�~� ¡��

23

�� �� KGJT�

1. ('��� 509 5� 1

2. ('�+ �� 959 20� 1

959 15� 3. PCR��

609 1� 40~50

£� �¢�£� ��6kI��

Ƣ�·�µº³ȓ5ȓtǼßZKX RNA ƵāKRk_BƢħƠ

ɁK<p=` Ct ì>40Y<o5Ƣ�·�µº³5×101 � º/ħƠ

B Ct-40 Z\URŔį]˨BƭʅMp6 £� �¢�¤� �&�

Ƣ�·�µº³ZKXɕ=R 5×101 @mb 5×100 � º/ħƠ_ĤɃ

RNA ƆȨÌɀ_>T55×100 � º/ħƠB Ct-40 _Ŕį` 5×100 � 

º/ħƠt55×100 � º/ħƠB Ct>40 _Ŕį` 5×101 � º/ħƠtĆů

ɕƢ�·�µº³ZKXâɕMp6 Ǽß_ Ct ìBĆůɕƢ�·�µº³_ Ct ì×¾_Ŕį]8Ƣ95Ćůɕ

Ƣ�·�µº³_ Ct ìmoŝCEÀV Ct ìB 40 ×¾_Ŕį]8Ćůç

ɛ95Ct ìB 40 moŝC=Ŕį]8Ƣ9ZĆǒMpņ 6 8Ƣ9ZĆůJqRŔį54-3� ɡzy³� E1 Ûŧ_Ǽā@mb

Ûŧ˞ǰ]ȳLXɡzy³�_Ûŧ˞ǰtŰǕMpIZBǂšJqp

6)68Ćůçɛ9_Ŕį]`5Ɵ˚]ƠLX5Ó_ă\Ǽßtɕ=XûǼǴ

tː>A5gR`İ»_ǼßY 4-2 �·¥·�°�³ RT-nested PCRNSÛŧŗƈȚ 55.zy³�Ă53.ˎȫūɪǼǴ\[tɕ=XĆůtː>Z

˃=6

24

ņ� ²w³�y« RT-PCR _Ćů¡µº�­º�

£� �¢�¥� òýöÿÝÛ)2�

˨tːURʟDz5Ƣ�·�µº³BǼāYC\=ʊ_ľB˪jnqR

Ŕį`5ĂȜKRć_�·�µº³tâɕMpʊ5ă]ŷƠMp6˨ʖ

]ľB˪jnqRŔį`430102/-�� 876 F�<@&.B�)5tĤ

ɃKX˨ʖ_û˧åtː>6

25

£�¡�� êĂøĂìüóÿ ·¹�ľÉʾ½� ¶­· Tċ�P�xh�ą´¸Ć��#"

-T�

Ǩ©�®w³Y`5ãZKX RT ħƠZ 1st PCR tĂGXː>ǔȚ Two-stepȚZʢKXː>ǔȚOne-step Țtˣ˻Mp6Two-Step ȚY`5

ɡ˦ǒ©�®w³ʉ 3 ɇ458zy³�ÛŧǼāȚ9]ˣ˻_ǔȚZù

_˨ˉtâɕMpǔȚtˣ˻KR6Ó_˨ˉtâɕMpŔį5ɡzy³

���«` GC ĴBƇ]=ʘ 70%Rj5 GC Ĵŏŗƈ]ŷ

ƠKR˸üħƠ˨ˉ@mb PCR ˨ˉTakara Bio ɹ Tks Gflex DNA polymerase ʊ_âɕtʮƫ]öqpZ˃=6 �

£�¡� ��¹ÍÅ�ÉÊ¾Æ TÚßá�eåäÿí ´¸ ��#ÛN��

£�¡� � ��w�

RNA Ƶā���»˂ɪ\ RNA Ƶā���@mbzy³� RNA Ƶā

��� ã High Pure Viral RNA kit µ�®w£±y��y|·�ɹ

tɕ=pIZBāǬp6 ˸üʚ [ãPrimeScript RT reagent kit (PerfectReal time)��

±�y~ɹ] PCR ʚ [ã PerfectShot Ex-taq (Loading dye mix) ��±�y~ɹ] NS Ûŧŗƈɕ£±y©º ɕ £±y©º

ı

˪ ˯ Ő

bp

ǔIJ Ą

NSL F3 5746-5762 F TCC TTG CGC CGA AGA CT 1st PCR

NSL B3-6 5984-6001 R AGA GGG GGT CCA CTT GAG

F2 nest 5811-5829 F CCA CTG AGA CCG GCT GCG A Nested

PCR B2 nest 5948-5967 R GCC TCG GGG AGG AAG ATG AC

FForward primer5RReverse primer

w�µº��³1.5~2.0% DNA Ăŧ©º�ºã100bp DNA Ladder �

£�¡� �¡�� åäÿí ·´¬ :��

RNA Ƶā`²w³�y« RT-PCR ȚZİǿ]ː> £� �¢� � åäÿí ·´¬

26

:�]ȳLp 6 £�¡� �¢�� ����2ą·¹Ć�

� IIY`5ħƠ]Ɵ˚\˨ˉB���_Å]MdXĴgqp PrimeScript RT reagent kit (Perfect Real Time)��±�y~ɹ˗tɕ=RǔȚtˣ

˻Mp6 ċ4-2-1-2YƵāKR RNA ȴȨ 10µL, 5)PrimeScript Buffer 4µL, PrimeScript RT Enzyme Mix I 1µL, Random 6mers 4µL, RNase Free dH2O 1µL tȪđKXʦ 20µL ]KRƘ537+15 Ă585+5 ɽ_y·�®

¥º�°·]mo cDNA įƭZ˸üʚ_¿ȠĘtː>6 RT ]moįƭJqR cDNA tɕ=5NS Ûŧ_Ǽā@mb˞ǰtː>6

RNA 10µL 5)PrimeScript Buffer 4µL PrimeScript RT Enzyme Mix I 1µL Random 6mers (100µM) 4µL RNase Free dH2O 1µL įˡ 20µL

£�¡� �£�� ÉÊ�¶­· ÔßÜ Ä¾Éʾ½�¶­· �2�

PCR `5ãZKX PCR �®º¢Å]£±y©ºtE52)PCR Master mix@mb Loading dye BĂȜJqR PerfectShot Ex Taq (Loading dye mix)��±�y~ɹ˗tɕ=RǔȚtɸM6 1) ×¾_˨ˉ@mb£±y©º���tȩįK5PCR ħƠtː>6

PerfectShot Ex-Taq 25µL cDNA 5µL Forward primer: NSL F3 (20µM) 1µL Reverse primer: NSL B3-6 (20µM) 1µL DNase/RNase free water 18µL įˡ 50µL

27

ħƠ ǫÙ �y�³Ǎ 1. Denaturation 94+ 3 Ă 1

Denaturation 98+ 10 ɽ Annealing 58+ 30 ɽ 2. PCR ħƠ Extension 72+ 45 ɽ

30

3. ǡʝ Extension 72+ 3 Ă 1 2) ×¾_˨ˉtȩįK5nested PCR ħƠtː>6

PerfectShot Ex-Taq 25µL 1st PCR ɔɉ 5µL Forward primer: F2 nest (20µM) 1µL Reverse primer: B2 nest (20µM) 1µL DNase/RNase free water 18µL įˡ 50µL

ħƠ ǫÙ �y�³Ǎ 1. Denaturation 94+ 3 Ă 1

Denaturation 98+ 10 ɽ Annealing 60+ 30 ɽ 2. PCR ħƠ Extension 72+ 45 ɽ

30

3. ǡʝ Extension 72+ 3 Ă 1 3) ȒȝĖ 1.5~2.0%w�µº��³TAE buffer âɕtɕ=5Mupid ª��³ȝĖ

ȁʊY 10µL _ PCR ɔɉtȝĖMp6|��z«¢µ©y�]mpdz˄Ƙ5

�±·�y³ª�º�ºYˌóǼāMp6ɡzy³�ÛŧBũŋKRŔ

į51st PCR _ŗƈɔɉZKX 256bp5nested PCR _ŗƈɔɉZKX 157bp_�·�B˪jnqp6 £�¡�¡��µÄ¾�ÉʾÆ�·¹�¶­· TÚßá�eåäÿí ´¸ ��#ÛN��

NS Ûŧ_Ǽā]` One-Step Țtɕ=RřȚtɕ=pIZBYCp6Ǽß

]`<4-2-1-2>]ȳLXƵāKR RNA tɕ=p6

28

�

£�¡�¡�  �w�

RT-PCR+ / [�VQIAGEN OneStep RT-PCR kit; QIAGEN�$] RNase Inhibitor [�:Recombinant RNase Inhibitor; MISPGH�] PCR+ / [�VTakara Ex-taqWMISPGH�] NS*�����QSGRU: 4-2-1-1A�?@DB £�¡�¡�¡�One-step RT-PCR ÔßÜ Nested PCR �2 ��B&">ECQSGRULNOF��?:RT-PCR��F#=;

RNase-Free dH2O 6.25 µl

5×Qiagen OneStep RT-PCR buffer 5 µl

5×Q Solution 5 µl

dNTP Mix 1 µl

Forward Primer NSL F3 (20 µM) 0.75 µl

Reverse Primer NSL B3-6 (20 µM) 0.75 µl

Qiagen One Step Enzyme Mix 1 µl

RNase Inhibitor (40U/µL) 0.25 µl

, RNA 5 µl

Total Volume 25µL

�� �� KGJT�

1. ('��� 509 30� 1

2. ('�+ �� 959 15� 1

Denaturation 949 30�

Annealing 589 30� 2. PCR��

Extension 729 1�

40

3. �! Extension 729 10� 1

��B&">ECQSGRULNOF��?:nested PCR��F#=;

dH2O 18.875 µl

10×Ex Taq buffer 2.5 µl

dNTP Mixture (2.5mM each) 2 µl

29

Forward Primer F2 nest (20 µM) 0.5 µl

Reverse Primer B2 nest (20 µM) 0.5 µl

Ex Taq (5U/µL) 0.125 µl

RT-PCR�� 0.5 µl

Total Volume 25µL

ȒȝĖ <4-2-1-4>Zİǿ]ȒȝĖtː=5Ûŧŗƈ_ɷ˪tː>6

�� �� KGJT�

1. Denaturation 949 3� 1

Denaturation 989 10�

Annealing 609 30� 2. PCR��

Extension 729 45�

25

3. �! Extension 729 3� 1

30

£�¢�� �eåäÿí ®  ��#ÛN�ÔßÜ��#|J � ÁɚçíȇWHO]mUX5ɡzy³�_ÛŧŏĂ`5E1

Ûŧú_ sequence window Ő739bp58731-9469 Ý_ÛŧĄtĤ

ɃǶ_ÛŧĄZȑ˺˞ǰMpIZYː>IZBůjnqX=p 9)6ʾƋ

ǼßÅ_zy³�An sequence window Ő÷t»Ǝ]ŗƈJOpIZ

BńY<pIZBś=Rj5ÌǒɆ]ĂGX RT-nested PCR YŗƈJOR

_T5ÛŧĄ˞ǰ]ɕ=p6ZC]²w³�y« RT-PCR l�·¥·�

°�³ RT-PCR Y NS Ûŧ_ǼāBīʵY<URŔįYk5E1 Ûŧ_

Ɇǔ_ǒɆ<p=`ÃǒɆBŗƈYC\=IZB<p6P_Ŕį5ǼßÅ_

zy³�ÛŧBź\=IZBʮ?nqpRj5zy³�ĂtːURƘ5

Ă�·£³tɕ=X E1 Ûŧ_Ǽā@mbÛŧ˞ǰtː>Z˃=6 £�¢� �� �w � <4-2. �·¥·�°�³ RT-nested PCR ȚǾˋɨ˳NSÛŧ

ŗƈȚ>YâɕMp˨ˉ<4-2-1-1 ˨ˉ>tĤɃ_IZ6\@<4-2-2>_One-Step RT-PCR ȚYɕ=p˨ˉ`ěĂ\ƩƎBƚnq\=Rj5ǨȚ]`

J\=_Ó5×¾_˨ˉtɕ=p6 E1 Ûŧŗƈɕ£±y©º 5’ǒɆ E1-(2) ɕ £±y©

ºı

˪ ˯ Ő

bp

Ą

E1-2F 8633-8652 AGC GAC GCG GCC TGC TGG GG 1st PCR

E1-2R*1 9119-9138 CCA GCG CGT ATG TGG AGT CC

E1-6F 8664-8683 ACA CCG TGA TGA GCG TGT TC Nested PCR

@mb�º�

|·�·�

E1-10R*2 9110-9129 ATG TGG AGT CCG CAC TTG CG

*1: E1-2R _Õso] E1-2Rmix BâɕīʵY<p 10)6

E1-2Rmix: CCR GCG CGT ATG TGG AGY CC

*2: E1-10R _Õso] E1-10Rmix BâɕīʵY<p 10)6

E1-10Rmix: ATG TGG AGY CCG CAC TTS CG

ąW�! R: A/G, Y: T/C, S: G/CĆ

31

3’ǒɆ E1-(3) ɕ £±y©

ºı

˪ ˯ Ő

bp

Ą

E1-7F 8991-9010 TTG TGG GGG CCA CGC CAG AG 1st PCR

E1-12R 9521-9540 TGT GTG CCA TAC ACC ACG CC

E1-3F 9070-9089 CGG CGA GGT GTG GGT CAC GC Nested PCR

@mb�º�

|·�·�

E1-3R 9473-9492 ACC CGC GCG CTC GCG CGA TC

PCR ɔɉʔ˗����ã: QIAquick PCR Purification Kit; �w�·ɹ�� DNA �³Ƶā����ã: QIAquick Gel Extraction Kit; �w�·ɹ�� �º�|·�·�����ã: BigDye® Terminators Cycle Sequencing Kit;

w£±y��y~���«�ɹ� �

£�¢�¡�� ÉÊ�¶­· ÔßÜ Ä¾Éʾ½�¶­·�

� 4-2-1-3.YˮǎKR cDNA tɕ=p6ħƠǫÙ`×¾]ɸM6�

1) PCR ħƠ PerfectShot Ex-Taq 25µL cDNA 5µL 5’ǒɆ E1-(2) 3’ǒɆ E1-(3) Forward primer (20µM) E1-2F E1-7F 1µL Reverse primer (20µM) E1-2R E1-12R 1µL DNase/RNase free water 18µL įˡ 50µL

ħƠ ǫÙ �y�³Ǎ 1. Denaturation 94+ 3 Ă 1

Denaturation 98+ 10 ɽ Annealing 61+ 30 ɽ 2. PCR ħƠ Extension 72+ 45 ɽ

30

3. ǡʝ Extension 72+ 3 Ă 1

32

2) ×¾_˨ˉtȩįK5nested PCR ħƠtː>6

PerfectShot Ex-Taq 25µL 1st PCR ɔɉ 5µL 5’ǒɆ E1-(2) 3’ǒɆ E1-(3) Forward primer (20µM) E1-6F E1-3F 1µL Reverse primer (20µM) E1-10R E1-3R 1µL DNase/RNase free water 18µL įˡ 50µL

ħƠ ǫÙ �y�³Ǎ 1. Denaturation 94+ 3 Ă 1

Denaturation 98+ 10 ɽ Annealing E1-(2): 59+ 30 ɽ

E1-(3): 66+ 30 ɽ 2. PCR ħƠ

Extension 72+ 45 ɽ

30

3. ǡʝ Extension 72+ 3 Ă 1 3) ȒȝĖ 1.5%w�µº��³TAE buffer âɕtɕ=5Mupid ª��³ȝĖȁʊ

Y 10µL _ PCR ɔɉtȝĖMp6|��z«¢µ©y�]mpdz˄Ƙ5�±

·�y³ª�º�ºYˌóǼāMp61st PCR _ŗƈɔɉ` 5’ǒɆ E1-(2)Y506bp, 3’ǒɆ E1-(3)Y 551bp _�·�ZKX˪jnqp6»ǔ5nested PCR_ŗƈɔɉ` 5’ǒɆ E1-(2)Y 466bp, 3’ǒɆ E1-(3)Y 423bp Z_�·�ZK

X˪jnqp6 £�¢�¢��¶­· b^Ûo{ØïäĀèòìĄèçĂí�2�

1) PCR ɔɉ_ʔ˗ � PCR ɔɉBȒȝĖYɷ˪YCR\na5PCR ɔɉ_ʔ˗tː>6ĝ»�

·�ZKX˪jnqRŔį]`Ƅ˰_ PCR ɔɉʔ˗���tɕ=pZʒæ

Y<p6�·�B˘Ǎ˪jnqRŔį]`5�³Anɭɪ_�·�_htă

oāKXʔ˗Mp6�º�|·�£±y©º`5Ƈ nested PCR ]âɕK

33

R£±y©ºtâɕMpIZBāǬp M\sT55’ǒɆ E1-(2)_Ŕį5E1-6FgR` E1-10R53’ǒɆ E1-(3)_Ŕį5E1-3F gR` E1-3R ņ 6£±

y©ºE1-3R tɕ=R�y´���º�|·�ħƠY`5țƖBCq=]ā

N5ěĂ\�º�tƚnq\=IZB<p6P_Ŕį`5£±y©ºE1-S4R: CGG CGG TGA CGA ACT TCC ą9405-9422 ŕŒŐ]ŷƠ tɕ=X˞ǰ

tː>6 2) �º�|·�ħƠ � ×¾_˨ˉ@mb£±y©ºtȩįK5�y�³�º�|·�ħƠtː>6

H2O 10µL Primer (3.2µM)* 1µL BigDye Terminator Ready Reaction Mix 8µL** ʔ˗ PCR ɔɉ5-20ng/µL 1µL

*Primer: 5’ǒɆ E1-(2)_Ŕį5E1-6F gR` E1-10R53’ǒɆ E1-(3)_Ŕį5

E1-3F gR` E1-3R<p=` E1-S4Rtɕ=p6 **BigDye Terminator Ready Reaction Mix`)5 BigDye sequencing bufferYƆīʵY<pB5ˀƆɎ`ĮʿYǼˢtː>Ɵ˚B<p6

ħƠǫÙ �y�³Ǎ 96+ 1 Ă 1

96+ 10 ɽ 50+ 5 ɽ 60+ 4 Ă

25

3) �º�|·�ħƠɔɉʔ˗@mb�º�|·�˞ǰ AutoSeq G-50GE ¤³��wʊtɕ=5ǦħƠ�y�ºª�º�ºt

ģMp6I_ʔ˗ɔɉt DNA �º�|·�º]mo˞ǰK5ÛŧĄ_

Ȗůtː>6 £�¢�£�� ìĄèçĂísKÛ|J�

� 5’ǒɆ@mb 3’ǒɆ_ÛŧĄƥœtV\DįsOX5739bp An\p

ÛŧŏȖůŐ8731-9469 Ý_ĄƥœtǾʑMpņ 6

34

ņ� ÛŧŏȖůŐsequence windowĸ˽_ cDNA Ą AÛŧŏȖůŐŗƈɕ£±y©º_˪˯Ý_ȃƑņ5 B

TO-336.GMK5 ǶTO-336 ¶��·Ƕ_˜Ƕ5Ûŧŏ 1a5accession number: AB588192_ĄtɸM6E1-(2)ǒɆ@mb E1-(3)ǒɆŗƈ£±

y©ºʟįÝt5PqQq˴@mbŨYɸM6ÛŧŏȖůŐ_ǡą

ZǡƘ_ 10 ŕŒNVtşŨYɸM6 � ɐŋ WHO BÅƞZ\UX5Įň_ŰűAnœķJqRɡzy³�

35

ÛŧƥœtkZ]ÛŧŏĂBːsqX=p 11)6ɐŋ_ZIrɡzy³

�`V_ Clade ]ŝCEĂGnqpIZBĆǚKX=p6Jn] Clade 1]` 10 V_Ûŧŏ1a, 1B, 1C, 1D, 1E, 1F, 1G, 1H, 1I, 1JB5Clade 2]`V_Ûŧŏ2A, 2B, 2CBũŋMp6w³¡v¥��_ŹǏŨY

˓ˣJqRÛŧŏ`Øprovisional_ÛŧŏY<p6WHO ]mUX

ůjnqRPqQq_Ûŧŏ_ĤɃǶ_Ą˓Z<sOXĂŧʖʠȅ

˞ǰtː>IZ]mo5ǼāJqRzy³�B[_Ûŧŏ]ĂJqp_

ABĆůYCpņ 6˿Ɗ5Ûŧŏ 1a zy³�`¶��·zy³�t

=XeZu[ǼāJqX=\=6I_RjǨÛŧŏzy³�BǼāJq

RŔį]`¶��·ǶY<pīʵƢBE5˪jnqpɤɋ`¶��·ǁʂ

_čħƠBɟsqp6¶��·ǁʂ_čħƠ_Ŕį]`ɡZ`˦ǒK\=6

gRÁɚĮňAnœķJqRĄ�º�tɕ=XĂŧɠūɪ\˞ǰBː?5

ǼāJqRzy³�]mpƩdzB˼öãAijAtĆćMpIZ\[BīʵZ

\p6 2013 Ɗ_ɡĹıȚ_NJů 11)Y`5IqgYØÛŧŏY<UR 1H, 1I, 1JBȊƑ\Ûŧŏ]ǙǸKR6đ?X»_ĤɃǶ_ǞǓ1H _»Ƕ@m

bıɾ_ǎɒB\JqR˓ 6 E1 Ûŧ˞ǰB\JqRŔį5 Ûŧŏƥœ]đ?5 ÛŧĄ]V=Xk

NESID ɣġßǼāƥœ���«]ɧtː>6NS ÛŧBǼāJqRk_

_5E1 Ûŧ˞ǰBāǬ\AURŔį]`5ŏć¿ǚnot typedZKX

NESID ɣġßǼāƥœ���«]ɧtː>6 gR5īʵ\o DDBJ ʊ_Ûŧ�º��·�c_ɧkː>IZBǂš

Jqp6

36

˓� ɡzy³�ĮÛŧŏ_ĤɃǶ

Û

ŧŏ

ĤɃǶ_Ǔıɾ

ĤɃǶ_ċıɾ

Ǩ©�®w³ʉÌɇˣ˻

Accession

Number

RVi/Brussels.BEL/0.63/(VAC) RVi/BEL/63[1a]VAC AF188704

RVi/New Jersey.USA/0.61/(VAC) RVi/NJ.USA/61[1a]VAC M30776

RVi/Pennsylvania.USA/0.64/(VAC) RVi/PA.USA/64[1a]VAC L78917

1a

RVi/Toyama.JPN/0.67/ Rvi/Toyama.JPN/67[1a] AB047330

RVi/Jerusalem.ISR/0.75/ RVi/Jerusalem.ISR/75[1B] AY968207

RVi/Tiberias.ISR/0.88/ RVi/Tiberias.ISR/88[1B] AY968209

1B

RVi/Bene Berak.ISR/0.79/ RVi/BeneBerak.ISR/79[1B] AY968208

RVi/California.USA/0.91/ RVi/Los Angeles.CA.USA/91[1C] AY968212

RVi/San Salvador.SLV/0.02/ RVi/SLV/02[1C] AY968211

1C

RVi/Panama City.PAN/0.99/ RVi/PAN/99[1C] AY968217

RVi/Tokyo.JPN/0.90/ Rvi/Tokyo.JPN/90CRS[1D] AY968214 1D

RVi/Saitama.JPN/0.94/ Rvi/Saitama.JPN/94[1D] AY968216

RVi/Shandong.CHN/0.02/ RVi/Dezhou.CHN/02[1E] AY968210 1E

RVi/Kuala Lumpur.MYS/0.01/ RVi/MYS/01[1E] AY968221

RVi/Shandong.CHN/0.00/ Rvi/Linqing.CHN/00[1F] AY968213 1F

RVi/Anhui.CHN/0.00/ RVi/Dangshan.CHN/00[1F] AY968215

RVi/Kampala.UGA/20.01/ Rvi/UGA/20.01[1G] EF588978

RVi/Ontario.CAN/27.05/ Rvi/Ontario.CAN/27.05[1G] EF588970

1G

RVi/Minsk.BLR/29.04/ RVi/Minsk.BLR/29.04[1G] AM258945

RVi/Minsk.BLR/28.05/2 Rvi/Minsk.BLR/28.05[1H] AM258953

RVi/Ryazan.RUS/09.08/ HG326276

1H

Rvi/Novokuznetsk.RUS/04[1H] EF421977

RVi/Milan.ITA/46.92/ Rvi/Milan.ITA/46.92[1I] AY161360 1I

RVi/London.GBR/0.86/ Rvi/London.GBR/86[1I] AF039122

RVi/Kagoshima.JPN/22.04/ Rvi/Kagoshima.JPN/22.04[1J] AB285129 1J

RVi/Miyazaki.JPN/10.01/ Rvi/Miyazaki.JPN/10.01[1J]CRS AB285130

RVi/Beijing.CHN/0.79/ RVi/Beijing.CHN/79[2A] AY258322 2A

RVi/Beijing.CHN/0.80/(VAC) RVi/Beijing.CHN/80[2A]VAC AY258323

37

RVi/TelAviv.ISR/0.68/ RVi/TelAviv.ISR/68[2B] AY968219

RVi/Washington.USA/16.00/ Rvi/Seattle.WA.USA/16.00[2B] AY968220

2B

RVi/Anhui.CHN/0.00/2 RVi/Anqing.CHN/00/2[2B] AY968218

RVi/Moscow.RUS/0.67/ Rvi/Moscow.RUS/67[2C] DQ388279 2C

RVi/Moscow.RUS/0.97/ Rvi/Moscow.RUS/97[2C] DQ085340

38

�

ņ� ɡzy³�ĤɃǶ@mbǗǨ_¶��·Ƕ]mpʖʠȅ E1 Ûŧ_ÛŧŏȖůŐ739bp_Ąƥœtɕ=X˿ǁįȚ]m

UX˞ǰtːUR6ɐŋ 13 ʂ_Ûŧŏ]ĂJqX=p6ǗǨ_¶��·

ǶTO-336 Ƕ5ǮȣǶ5ȆǶ@mb÷ÁɚYÆ]âɕJqp¶��·Ƕ

RVi/Pennsylvania.USA/0.64/(Vac), ćı RA27/3 Ƕ`Ûŧŏ 1a ]Ă

RVi/Brussels.BEL/0.63/(VAC)

Takahashi(VAc;Kitasato)

RVi/New Jersey.USA/0.61/(VAC)

1a

RVi/San Salvador.SLV/0.02/

RVi/California.USA/0.91/

RVi/Panama City.PAN/0.99/

1C

RVi/Toyama.JPN/0.67/

TO-336(Vac;Takeda)

Matsuura(Vac;Biken)

RVi/Pennsylvania.USA/0.64/(VAC)

1a

RVi/Tiberias.ISR/0.88/

RVi/Bene Berak.ISR/0.79/

RVi/Jerusalem.ISR/0.75/

1B

RVi/Minsk.BLR/29.04/

RVi/Ontario.CAN/27.05/

RVi/Kampala.UGA/20.01/

1G

RVi/Ryazan.RUS/09.08/

RVi/Minsk.BLR/28.05/2/1H

Rvi/London.GBR/0.86/

RVi/Milan.ITA/46.92/1I

RVi/Tokyo.JPN/0.90/

RVi/Saitama.JPN/0.94/1D

RVi/Kuala Lumpur.MYS/0.01/

RVi/Shandong.CHN/0.02/1E

RVi/Miyazaki.JPN/10.01/

RVi/Kagoshima.JPN/22.04/1J

RVi/Shandong.CHN/0.00/

RVi/Anhui.CHN/0.00/1F

RVi/Beijing.CHN/0.80/(VAC)

RVi/Beijing.CHN/0.79/2A

RVi/TelAviv.ISR/0.68/

RVi/Washington.USA/16.00/

RVi/Anhui.CHN/0.00/2/

2B

RVi/Moscow.RUS/0.97/

RVi/Moscow.RUS/0.67/2C

0.01

39

Jqp6 £�£�� þãÿîäú ·¹�¶­· ÔßÜêĂøĂìüóÿ ·¹�¶­· Û�3êĂò

āĄÿ�

½ˣ RT-PCR ]âɕMpƢ�·�µº³`ňʅƩdzɤɶʄƮzy³�ʉ¼

ʉÌűYƅKX=p6 ¤�� åäÿí���

zy³�_Ă@mbİů]` 3;t˚Mp6 ¤� �� �cqu�

śE_ʜʴBɡzy³�ƩĪƢY<pB5Vero5VeroE6 @mb RK-13 ʜ

ʴBňúŚY_ŰʨBś=6\@5ʾƋɤɋʊmoɡzy³�ƩdzZęć

Bń\Ŕį`5ɡzy³�_ĂǔȚ]ĊK5�� SLAM ɦɐ Vero ʜ

ʴtɕ=XĂtː>IZkīʵY<p6gR5ɡzy³�_ŗȌ`Ƴɲ

ˆČ_¡v·��·]mUXƲĉJqp_Y5zy³�Ă_Rj_őȨ

]`đ?\=ǔBm= 12)6 ¤�¡�� ��AT�

×¾`ňʅƩdzɤɶʄƮYŰǕKX=pǔȚRK-13 ʜʴâɕtkZ]ˣ

˻MpB5ʜʴʂ]mpƃlİLʜʴYkˀőŌ_ǫÙBɞ\p_Y5Į

ǼǴű]X˩ʜ`ǼˢMpIZBǤgK=6 %ɈˎȫBStȪđKR Eagle’s MEM ]ȤJOR RK13 ʜʴ

3)10cells/mlt£±����¡±��12.5cm2]»Ǩ<Ro

4ml5kKE` 6 ʃ£´º�»ʃƕRo 3mL tLJʂK537+_ȿ�

�őłY 2 ǗőMp6 0.2ml _ǼßtǁʂMp6űȯY 1 ǜĵɳKRƘ5ǁʂǩǑt_Q

AN] 2%BStĴiőȨt 4mlđ? 35~37+_ȿ��őłYő

Mp35+_ǔBǤgK=B 37+YkĂīʵY<p 6ǼßBŻ

_Ŕį`ǁʂǩǑt=RƘ]őŌtđ?pŻ`ʜʴc_ȐƢBƔ

=Rj 6ʭǗ]ʜʴřƭĕDz(CPE)BhnqRŔį`�·£³_Ɋ

ɞɪ\ȐƢ]mpZʮ?nqp_YǓK=őȨ]ÏDžMp6ǁʂƘ

40

4 Ǘɭ]őȨtÏDžK5ǁʂƘ 7 ǗɭgYőtʢGp6ƇI_

ȍY`zy³�]mp CPE `hnq\=6 ƩdzʜʴtőȨZZk]þʟˍ˞K5P_»(1ml)tǓK=ʜʴ]

ǁʂK5İǿ]őMp6ƇI_ʡÕőtŃʩoMB5CPEB˝ŶYCpm>]\qaŃǍtȭnMIZBYCp6őʝÉƘʜ

ʴtþʟˍ˞K5P_Ƙ 3000rpm520 Ă_ƞ½ȫtĂ˨ǑZK

zy³�İůtː>6»˂]ɡzy³�]mpCPE`Ɠ=RjCPEB˝ŶYC\EZkĂ˨ǑÅ]ɡzy³�BũŋKX=pīʵƢ

BěĂ]<p6gRɡzy³�]mp CPE `ɊƝB\=_Y CPE˝Ŷ]mpĂİů_Ćů`ËŰ½ńY<p6

¤�¢�� �&AT�

ɡzy³�_İů]`zy³�ÛŧǼāRT-PCR 5ˌóƳßȚ]mp

zy³�ƳġǼā5Ƴˎȫ]mpÅĺȚʊB<pB5ÅĺȚ`ǜBAAp

IZlÅĺƳß_ɷç\[ƯBAApRjǂšK\=6Ǩ©�®w³Y`

ÛŧǼāȚ ǖ @mbˌóƳßȚ]mpƳġǼāȚtˣ˻Mp6\@5

ĆůgY_ǜBɵE5Ăŧɠūɪ\˞ǰkīʵZ\pzy³�ÛŧǼā

tʉ»ƴZKXâɕMpIZBǂšJqp6 ¤�¢� �� y�9�T�

âɕʜʴ¹˨ˉʊ`zy³�ĂZİǿ_k_tâɕMpB5ʜʴ_ő`

�±�˗�­·�º�±y�8 �­·�ºʊYː>6 1) RK-13 ʜʴt�­·�º�±y�YőK5Ă˨Ǒ 25*l tǁʂK

35~37+Y 1 ǜNjʪƘ5őȨt 0.4ml đ? 35~37+_ȿ��ő

łúYőMp 2) ƩdzƘ CPE BɐqRnʘ 3-4 Ǘ5CPE B˪jnq\=ŔįYk 5-7

ǗɭY 5ʜʴt PBS YȟȢKRƘ54%�±§³«w³���Y 30 Ă

ŇůMp6PBS YȟȢƘ50.5%TritonX-100 đ PBS tűȯ 15 ĂYƩ

àK5ʽĀɒtMp6 3) ŇůKRʜʴ]»ȈƳßZKXƄ˰JqX=pƳɡzy³�ʔ˗©z

�¬��µº�³Ƴß ã abcam ab34749, USBiological R9700-05A

t 1;2*g/mL ]ƆK5»ęə<Ro 100~200*l đ?5çȱʎ]öq

41

37+1 ǜĀɒMp6 4) PBS Y 5-6 ŃȟȢƘ5FITC Ȃ˯Ƴ©z� IgG Ƴß ȻƎ]kmpB 1

300;500 Ɔt 100~200*l _Oçȱʎ]öq 37+1 ǜħƠJOp 5) PBS Y 5-6 ŃȟȢƘ5ˌó˝ŶɕŸöČt_OX��º�±�t@C5

ˌóƜY˝ŶMp6İǿ]ĀɒKRƩdzʜʴtŷɃZK5ɡz

y³�]Ɋɞɪ\ˌóBǼāJqpŔįtɡzy³�ƢZĆůMp6

¥�� N�åäÿíÛ��T�

WHO ]mUX5ɡzy³�ŚǶ_ĹıǔȚB×¾_o]ɸJqX=

p 11)62013 Ɗ_NJˠYƊ_ƥœˣ˻ʊB»řǞJqR6 1)ʾƋǩǑAnʜʴő]moĂJqRzy³�Ƕ RVi/City.Country/Weeks.Year/isolation number[Genotype] 2)ʾƋǩǑɗǬ RNA AnÛŧBǼāJqRzy³�Ƕ RVs/City.Country/Weeks.Year/isolation number[Genotype] CityʾƋǼß_ƚnqRƍɱıgR`njÖƺůƄı6njÖƺůƄ

ı_ǜ` C(city) tVGp6 CountryʾƋǼß_ƚnqRňı_ɜɾǗǨ_Ŕį JPN Weeks.Yearɦɤɠū@mbɦɤƊtˣ˻Mp6ɡ_Ŕį5ɦɡ

ZɦɄ`efİǜ]āɐMpB5=NqA_ɤɋKA˪jnq\=Ŕįl¿

Ƣ_ŔįB<p6gR5ɦɤǗgR`ɤɋ_ʂ_ƥœBƚnq\=IZ

B<p6P_Rj5ɦɤƊZKX`×¾_]ðòƎ_=Ǘǜt˵ɀ

ZKXˣ˻Mp6�

.ɦɡāɐǗ�

/ɦɡB˪jnq\=ŔįkKE`ɤɋ_ʂƥœBƚnq\=Ŕį5\u

nA_ɦɤ_āɐǗ�

0ɦɤǗ_ƥœBƚnq\=Ŕį5ǼßǀĩǗ6�

\@5Ɗƥœ`5˙ǝ_¾Ìǹ_htˣ˻Mp6�

Isolation numberƤʯ_ɦɓKRƄ@mbɦɤBİ»_zy³�ǶB

˘ǍũŋMpŔį51 An]ǎɒɝĭtˣ˻~£�°·

42

GenotypeÛŧŏ òŞƢɡɤëʬCRSƤʯ5òŞƢɡƩdzCRIʯ_ʾƋǩǑAn

ƚnqRzy³�Ƕ]`[Genotype]_Ƙr]PqQq(CRS)5(CRI)Zˣ˻M

p6ÃʯZk City, Country ]`āɓŌ5Weeks, Year ]`āɓǗǼßǀ

ĩǗY`\EtɕMp6 ¶��·Ƕ]`[Genotype]_Ƙr](VAC)Zˣ˻Mp6 ãŰŋMpk_Y`<ogOu ã1998 Ɗ 3 ɭ]ǭÐYɦɤKRƤʯAnƚnqRzy³�ǶY5

İ»_Ƥʯ_>Tɝɭ]˞ǰJqRk_6zy³�BĂJqX@o5

Ûŧŏ` 1D6 RVi/Tokyo.JPN/03.98/2[1D] ã 2009 Ɗ 28 ɭ]ɻƀƄYāɓKR CRS ƤʯɗǬ_zy³�6zy

³�ÛŧBǼāJqX@o5Ûŧŏ` 1B6 RVs/FukuokaC.JPN/28.09/[1B](CRS) 7. �����1) ĠɓĔïɰķɸʉɩÌěÌĭKu]MpɊůƩdzɤÊƺ5Ɖƭ

26 Ɗ 3 Ǣ 28 Ǘ 2) ƉġĬȅeAɡȡː@mbòŞƢɡɤëʬ_ɦɓƲĉ]Mpʥơ

DŽ˟6ĠɓĔïɼūɶʄ˲˖ē� Ǔˁ¹ûˁƩdzɤɶʄËǽĂƶɶʄ

ɏ� ɡȡː]Zk\>ȎŧƩdz_ÊŷʋǾʑ]Mpɶʄ52004. 3) World Health Organization: Manual for the laboratory diagnosis of

measles and rubella virus infection. Second edition. WHO/IVB/07.01. 2007.

4) ȽėĿeAɡ˦ǒ©�®w³ʉɇ 52015. 5) ňʅƩdzɤɶʄƮzy³�ʉ¼Ʃdzɤɠū�·�ºKuƳßå_

Džʌ˭hǠ?]MpǼˢ5ňʅƩdzɤɶʄƮ§º«¦º�52014Ɗ 6 ǢNJˠɇ

6) đˊ˅Ūɡ HI ƳßåȰů_ˑƑ6ʾ ƋZzy³�519(2)5127-13051991.

43

7) đˊ˅ŪˎȫĀɒɕ�~²·_Āɒ`Ɵ˚ǫÙY`\=6ʾƋZzy

³�522(2)5S7551994. 8) Inouye, S.: Micro-modification of kaolin treatment of serum for the

rubella hemagglutination-inhibition test. J. Med. Microbiol., 9, 501-502, 1976.

9) World Health Organization: Standardization of the nomenclature for genetic characteristics of wild-type rubella viruses. Wkly. Epidemiol. Rec., 80(14), 126-132, 2005.

10) Yasui et al.: Detection and genotyping of rubella virus from exanthematous patients suspected of having measles using reverse transcription-PCR. Jpn. J. Infect. Dis., 67, 389-391, 2014.

11) World Health Organization: Rubella virus nomenclature update: 2013. Wkly. Epidemiol. Rec., 88(32), 337-348, 2013.

12) Umino, Y and Tashiro, M.: Inhibition of rubella virus growth by Fungizone. Vaccine, 19, 1369-1372, 2001.

��������

¹÷ňƍɱ/njÖƄ˒ɓɶʄƮ�

¹ňʅƩdzɤɶʄƮzy³�ʉ¼�

:208-0011ǭÐȋˈǪſƄūʼn�4-7-1

Tel:042-561-0771

Fax:042-565-3315

�

��� ����

� ʉ»ɇƉƭ 14 Ɗ 3 Ǣ � ʉÌɇƉƭ 24 Ɗ 12 Ǣ � ʉ¼ɇƉƭ 27 Ɗ 3 Ǣ � ʉ 3.1 ɇƉƭ 27 Ɗ 8 Ǣ � ʉ 3.2 ɇƉƭ 29 Ɗ 8 Ǣ²w³�y« RT-PCR ˨ǡĘ]@GpĤ

Ƀ RNA Ɔȍ_řǞ �

�

44

������

ǻ� Łɓ5ŝȀʗÇ5ƀǨ˱Áŧ5ōɖɲĬ5ʈɖ˫ňʅƩdzɤɶʄƮz

y³�ʉ¼ ŬÎŀŮ5ɫƁȞŧƨɴɱ˒ɓɶʄƮ èɖ˱ŧ5½DZŝ˵5đȽĽɘŝƍøˏ˒ɓɶʄƮ �